EUVIMEDEUVIMED entdecken
Open Access

LncRNA LMCD1-AS1 Interacts with PHF8 to Promote Hepatocellular Carcinoma Resistance to Multikinase Inhibitors

Xiao Yang, Songze Song, Tianxing Ye, Xiujuan Zhang, Ziying Yang, Yue Mi, Yanjie Shen, Yanan Zhang, Jie Liu, Qinong Ye

International Journal of Biological Sciences · 30.03.2026 · 22 (8) · 3990-4003

DOI: 10.7150/ijbs.129651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 30.03.2026. Verfasst von Xiao Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRNA, Long NoncodingDrug Resistance, NeoplasmHistone DemethylasesProtein Kinase InhibitorsTranscription FactorsHumansAnimalsCell Line, TumorMiceSorafenibGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

drug resistanceepigenetic reprogramminghepatocellular carcinomalncRNAmultikinase inhibitor

Substanzen

RNA, Long NoncodingHistone DemethylasesProtein Kinase InhibitorsPHF8 protein, humanTranscription FactorsSorafenib

Autor:innen und Institutionen

  • National Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
  • Department of Cell Biology, Key Laboratory of Cell Biology of National Health Commission of the PRC, China Medical University, Shenyang 110122, China.
  • Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beiing), Gastrointestinal Cancer Center, Peking University Cancer Hospital &Institute, Beijing 100142, China.
  • Key Laboratory of Xinjiang Phytomedicine Resources and Utilization, Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832002, China.
  • School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China.

Zitieren

APA

Yang, X., Song, S., Ye, T., Zhang, X., Yang, Z., Mi, Y., Shen, Y., Zhang, Y., Liu, J., & Ye, Q. (2026). LncRNA LMCD1-AS1 Interacts with PHF8 to Promote Hepatocellular Carcinoma Resistance to Multikinase Inhibitors. International Journal of Biological Sciences, 22(8), 3990-4003. https://doi.org/10.7150/ijbs.129651

Vancouver

Yang X, Song S, Ye T, Zhang X, Yang Z, Mi Y, et al. LncRNA LMCD1-AS1 Interacts with PHF8 to Promote Hepatocellular Carcinoma Resistance to Multikinase Inhibitors. International Journal of Biological Sciences. 2026;22(8):3990-4003. doi:10.7150/ijbs.129651

BibTeX
@article{Yang2026,
  author = {Yang, Xiao and Song, Songze and Ye, Tianxing and Zhang, Xiujuan and Yang, Ziying and Mi, Yue and Shen, Yanjie and Zhang, Yanan and Liu, Jie and Ye, Qinong},
  title = {LncRNA LMCD1-AS1 Interacts with PHF8 to Promote Hepatocellular Carcinoma Resistance to Multikinase Inhibitors},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {8},
  pages = {3990--4003},
  doi = {10.7150/ijbs.129651}
}
Kostenlos starten →